I am a
Home I AM A Search Login

Papers of the Week

Papers: 29 May 2021 - 4 Jun 2021

Human Studies, Pharmacology/Drug Development

2021 May 28

Clin Ther

Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies.


Kato J, Baba M, Kuroha M, Kakehi Y, Murayama E, Wasaki Y, Ohwada S
Clin Ther. 2021 May 28.
PMID: 34059327.


Mirogabalin besylate has been approved in several countries to treat peripheral neuropathic pain. This pooled analysis, using data from the two pivotal Phase III studies in Asian patients with diabetic peripheral neuropathic pain and post-herpetic neuralgia, aimed to provide clinicians with more detailed and precise information relating to mirogabalin's safety and efficacy.